SYNTA PHARMACEUTICALS

Serial Number 76977979
Registration 3125571
800

Registration Progress

Application Filed
Jan 12, 2005
Under Examination
Approved for Publication
Apr 26, 2006
Published for Opposition
May 16, 2006
Registered
Aug 8, 2006

Trademark Image

SYNTA PHARMACEUTICALS

Basic Information

Serial Number
76977979
Registration Number
3125571
Filing Date
January 12, 2005
Registration Date
August 8, 2006
Published for Opposition
May 16, 2006
Renewal Date
August 8, 2016
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Sep 11, 2015
Registration
Registered
Classes
005

Rights Holder

Synta Pharmaceuticals Corp.

03
Address
45 Hartwell Avenue
Lexington, MA 02421

Ownership History

Synta Pharmaceuticals Corp.

Original Applicant
03
Lexington, MA

Synta Pharmaceuticals Corp.

Owner at Publication
03
Lexington, MA

Synta Pharmaceuticals Corp.

Original Registrant
03
Lexington, MA

Legal Representation

Attorney
Roberta Jacobs-Meadway

USPTO Deadlines

Next Deadline
391 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2006-08-08)
Due Date
August 08, 2026
Grace Period Ends
February 08, 2027

Application History

30 events
Date Code Type Description
Jun 2, 2016 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 11, 2015 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 11, 2015 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 11, 2015 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 11, 2015 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 12, 2015 E89R I TEAS SECTION 8 & 9 RECEIVED
Aug 8, 2015 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 26, 2014 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2012 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 26, 2012 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 26, 2012 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 13, 2012 E815 I TEAS SECTION 8 & 15 RECEIVED
Mar 26, 2008 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 8, 2006 R.PR A REGISTERED-PRINCIPAL REGISTER
May 16, 2006 PUBO A PUBLISHED FOR OPPOSITION
Apr 26, 2006 NPUB O NOTICE OF PUBLICATION
Mar 24, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 17, 2006 ALIE A ASSIGNED TO LIE
Mar 16, 2006 AUPC I AMENDMENT TO USE PROCESSING COMPLETE
Mar 16, 2006 IUAA P USE AMENDMENT ACCEPTED
Mar 16, 2006 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2006 MNDA O NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED
Feb 10, 2006 DPCC D DIVISIONAL PROCESSING COMPLETE
Jan 31, 2006 MAIL I PAPER RECEIVED
Jan 31, 2006 DRRR I DIVISIONAL REQUEST RECEIVED
Jan 31, 2006 IUAF S USE AMENDMENT FILED
Aug 17, 2005 CNRT F NON-FINAL ACTION MAILED
Aug 16, 2005 CNRT R NON-FINAL ACTION WRITTEN
Aug 12, 2005 DOCK D ASSIGNED TO EXAMINER
Jan 26, 2005 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
PHARMACEUTICAL PRODUCTS, NAMELY, DRUGS FOR INFLAMMATORY DISEASES AND CANCER
First Use Anywhere: Jul 15, 2002
First Use in Commerce: Jul 15, 2002

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
PHARMACEUTICALS

USPTO Documents

Loading USPTO documents...